rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    BNTC
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Wedbush raises Benitec BioPharma stock price target on FDA feedback
      Nov 16Investing.comBNTC
      Benitec reports positive trial data for rare muscle disorder drug
      Nov 13Investing.comBNTC
      Benitec Biopharma Releases First Quarter 2027 Fiscal-Year Financial Results and Provides Operational Update
      Nov 13Yahoo FinanceBNTC
      Benitec reports positive interim results for OPMD gene therapy
      Oct 28Investing.comBNTC
      Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301
      Oct 28Yahoo FinanceBNTC
      Raymond James initiates Benitec BioPharma stock with outperform rating
      Oct 23Investing.comBNTC
      Raymond James Initiates Coverage on Benitec Biopharma With Outperform Raring, $14 PT
      Oct 23Yahoo FinanceBNTC
      H.C. Wainwright reiterates Benitec stock rating on FDA feedback
      Oct 6Investing.comBNTC
      Citizens reiterates Benitec Biopharma stock rating on FDA feedback
      Oct 6Investing.comBNTC
      Benitec receives FDA feedback on BB-301 pivotal trial design
      Oct 5Investing.comBNTC
      Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study
      Oct 5Yahoo FinanceBNTC
      Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Benitec Biopharma (BNTC)

      Detailed price information for Benitec Biopharma Ltd ADR (BNTC-Q) from The Globe and Mail including charting and trades.

      Sep 29The Globe and MailBNTCRGNX
      H.C. Wainwright reiterates Benitec Biopharma stock rating at buy
      Sep 28Investing.comBNTC
      After Plunging 23.9% in 4 Weeks, Here's Why the Trend Might Reverse for Benitec Biopharma (BNTC)
      Sep 25Yahoo FinanceBNTC
      Benitec Biopharma appoints Ernst & Young as new auditor, replaces Baker Tilly
      Sep 24Investing.comBNTC
      Analysts Conflicted on These Healthcare Names: High Tide (HITI), Cardiff Oncology (CRDF) and Benitec Biopharma (BNTC)

      Detailed price information for Benitec Biopharma Ltd ADR (BNTC-Q) from The Globe and Mail including charting and trades.

      Sep 16The Globe and MailBNTCCRDF
      Analysts Offer Insights on Healthcare Companies: Benitec Biopharma (BNTC), CVS Health (CVS) and BioNTech SE (BNTX)

      Detailed price information for CVS Corp (CVS-N) from The Globe and Mail including charting and trades.

      Sep 16The Globe and MailBNTC
      Wedbush Lifts Price Target on Benitec Biopharma to $17 From $16, Keeps Outperform Rating
      Sep 15Yahoo FinanceBNTC
      Citizens reiterates Benitec Biopharma stock rating ahead of FDA talks
      Sep 15Investing.comBNTC
      Benitec completes patient follow-up, plans pivotal trial in 2027
      Sep 14Investing.comBNTC
      Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update

      All six Cohort 1 (low dose BB-301) patients have completed the full 12-month post-treatment follow-up period, and Cohort 2 (high dose BB-301) is fully enrolled with all three patients having been safely treatedA Type C meeting was held with the U.S. Food and Drug Administration in 3Q2026 to discuss the BB-301 pivotal study design, and meeting minutes are anticipated in OctoberAdditional interim clinical study results from the ongoing BB-301 Phase 1b/2a trial have been accepted for late-breaking

      Sep 14Yahoo FinanceBNTC
      Benitec Biopharma Files $200 Million Shelf Registration

      Benitec Biopharma (BNTC) filed a registration statement Monday with the US Securities and Exchange C

      Sep 14Yahoo FinanceBNTC

      This is the newest page. Registered accounts read further back.